Ocular Therapeutix, Inc.
NASDAQ:OCUL
10.39 (USD) • At close November 1, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operationele Activiteiten: | ||||||||||||
Nettowinst
| -80.736 | -71.038 | -6.553 | -155.636 | -86.372 | -59.978 | -63.386 | -44.703 | -39.748 | -28.648 | -13.317 | -14.093 |
Afschrijvingen & Amortisatie
| 2.983 | 2.109 | 2.421 | 2.773 | 2.53 | 2.286 | 1.625 | 0.881 | 0.754 | 0.547 | 0.404 | 0.404 |
Uitgestelde Inkomstenbelasting
| 4.602 | 0 | -78.122 | 86.189 | -4.303 | 0 | 0.009 | 1.418 | -0.058 | 0.332 | -0.014 | 0.049 |
Aandelen Gebaseerde Vergoedingen
| 17.825 | 16.964 | 14.977 | 7.531 | 8.759 | 7.483 | 7.321 | 5.956 | 4.64 | 2.644 | 0.476 | 0.243 |
Verandering in Werkkapitaal
| -7.411 | 1.349 | -2.901 | 1.175 | -1.875 | 0.585 | 3.55 | 2.076 | 0.503 | 2.162 | -0.24 | 0.726 |
Vorderingen
| -4.854 | -0.19 | -8.883 | -9.704 | -2.347 | 0.025 | 0.024 | -0.057 | 0.136 | -0.06 | -0.224 | 0.077 |
Voorraden
| -0.331 | -0.724 | -0.049 | -0.247 | -0.737 | -0.095 | -0.009 | 0.021 | -0.001 | -0.133 | -0.092 | 0.496 |
Crediteuren
| 0.583 | -0.621 | 1.796 | -0.452 | 0.124 | -0.796 | 0.932 | -0.159 | 0.348 | 0.507 | -0.174 | 0.145 |
Overig Werkkapitaal
| -2.809 | 2.884 | 4.235 | 11.578 | 1.085 | 1.451 | 2.603 | 2.271 | 0.02 | 1.848 | 0.25 | 0.008 |
Overige Niet-Contante Posten
| -7.497 | -8.987 | 4.628 | 4.414 | 3.683 | 0.397 | 0.408 | 0.371 | 0.166 | 2.467 | 0.046 | 0.086 |
Kasstroom uit Operationele Activiteiten
| -70.234 | -59.603 | -65.55 | -53.554 | -77.578 | -49.227 | -50.473 | -34.001 | -33.743 | -20.496 | -12.645 | -12.585 |
Investeringsactiviteiten: | ||||||||||||
Investeringen in Materiële Vaste Activa
| -6.087 | -3.715 | -1.194 | -0.841 | -2.238 | -1.889 | -8.252 | -1.919 | -1.778 | -1.26 | -0.387 | -0.203 |
Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0.005 | 0.002 | 0.007 | 0 | 0 | 0 |
Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | -3 | -41.699 | -91.684 | -37.326 | 0 | 0 |
Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 38.2 | 80.684 | 54.826 | 0 | 0 | 4.017 |
Overige Investeringsactiviteiten
| 0 | -3.715 | 0 | 0 | 0 | 0 | 0.114 | -1.5 | 0.06 | -37.326 | 0 | 4.017 |
Kasstroom uit Investeringsactiviteiten
| -6.087 | -3.715 | -1.194 | -0.841 | -2.238 | -1.889 | 27.067 | 35.568 | -38.569 | -38.586 | -0.387 | 3.814 |
Financieringsactiviteiten: | ||||||||||||
Schuldaflossingen
| -51.165 | 0 | -0.445 | -3.201 | -37.275 | -5.657 | -2.4 | 0 | -1.5 | -2.273 | -1.818 | -0.909 |
Uitgifte van Gewone Aandelen
| 118.663 | 1.454 | 3.296 | 228.014 | 38.066 | 61.571 | 30.199 | 1.104 | 66.176 | 69.518 | 0 | 0 |
Terugkoop van Gewone Aandelen
| 0.851 | 0 | 0.985 | 0.747 | 0.451 | 0.297 | 0.276 | 0 | 0.249 | 0.064 | 0 | 0 |
Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Overige Financieringsactiviteiten
| -5.184 | 1.454 | -0.275 | 228.014 | 38.066 | 12.726 | 29.608 | 0.585 | 2.882 | 26.573 | 8.501 | 28.204 |
Kasstroom uit Financieringsactiviteiten
| 169.828 | 1.454 | 2.851 | 228.014 | 75.341 | 68.64 | 32.008 | 0.585 | 65.703 | 78.97 | 6.683 | 27.295 |
Overige Informatie: | ||||||||||||
Effect van Wisselkoersveranderingen op Kas
| 0.15 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Netto Kasstroomverandering
| 93.657 | -61.864 | -63.893 | 173.62 | -4.475 | 17.524 | 8.602 | 2.152 | -6.609 | 19.888 | -6.349 | 18.524 |
Kaspositie aan het Einde van de Periode
| 195.957 | 104.064 | 165.928 | 229.821 | 56.201 | 60.676 | 41.538 | 32.936 | 30.784 | 37.393 | 17.505 | 23.854 |